Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 88,162 |
|
|||||
| News | - | ||||||
| Day High | 1.8133 | Low High |
|||||
| Day Low | 1.50 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Predictive Oncology Inc | POAI | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.055 | -3.31% | 1.605 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.69 | 1.50 | 1.8133 | 1.51 | 1.66 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 529 | 88,162 | US$ 1.64 | US$ 144,386 | - | 1.12 - 7.12 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:30:51 | 52 | US$ 1.56 | USD |
Predictive Oncology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.14M | 4.06M | - | 1.78M | -13.98M | -3.44 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Predictive Oncology News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical POAI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.25 | 1.85 | 1.12 | 1.40 | 112,044 | 0.355 | 28.40% |
| 1 Month | 2.62 | 2.62 | 1.12 | 1.57 | 54,702 | -1.02 | -38.74% |
| 3 Months | 3.01 | 3.76 | 1.12 | 2.23 | 33,890 | -1.41 | -46.68% |
| 6 Months | 3.00 | 3.76 | 1.12 | 2.57 | 25,229 | -1.40 | -46.50% |
| 1 Year | 3.08 | 7.12 | 1.12 | 3.73 | 61,911 | -1.48 | -47.89% |
| 3 Years | 21.20 | 32.80 | 1.12 | 16.87 | 780,275 | -19.60 | -92.43% |
| 5 Years | 11.62 | 107.80 | 1.12 | 22.40 | 959,819 | -10.02 | -86.19% |
Predictive Oncology Description
| Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response. |
